Wed 10/17/2018 06:13 ET
DJIA25798.42547.872.17%TELCO166.070.400.24%GOLD1230.700.250.02%Shanghai2561.6115.370.60%
S&P 5002809.9260.412.15%BANKS450.795.321.18%OIL71.610.310.43%BITCOIN6530.1052.240.80%
NASDAQ7645.49220.952.89%PHARM577.0010.561.83%US/EU1.170.000.26%Futures2811.006.750.24%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neovasc - NVCN   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NVCN
  
From: kyleLennon (Rep: 0)Date: 08/07/2018 11:07
Forum: Neovasc - Msg #652Thread #674026455 (Rec: 0)
Just yesterday Neovasc resolved potential legal claims that could be brought against the company with the University of Pennsylvania (a.k.a. Penn). The firm has signed a collaboration and licensing agreement with Penn's Gorman Cardiovascular Research Group. Based on the agreement, for a period of time over the next four years Neovasc will pay a fee to Penn. The company will also pay a royalty on Tiara, its cornerstone product, to Penn. This agreement does not impact either Penn's or Neovasc's patent rights, and it also contains buyout clauses which allow a potential acquirer to buy out the royalty obligations.

NVCN: https://www.finstead.com/bite/Neovasc-NVCN-stock-forecast-prediction-august-4-2018

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser kyleLennon: Reward | Watch | IgnoreNVCN: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NVCN
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.